Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

BSGM
BioSig Technologies, Inc. Common Stock
stock NASDAQ

At Close
May 8, 2025 3:59:30 PM EDT
1.79USD+21.769%(+0.32)711,688
1.78Bid   1.81Ask   0.03Spread
Pre-market
May 8, 2025 9:06:30 AM EDT
1.55USD+5.429%(+0.08)11,942
After-hours
May 8, 2025 4:45:30 PM EDT
1.82USD+1.676%(+0.03)13,872
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
01:03PM EST  BioSig Awarded U.S. Patent Claims For Its PURE EP Noise-Filtering Technology   Benzinga
01:00PM EST  BioSig Awarded US Patent Claims for its PURE EP   GlobeNewswire Inc
Jan 25, 2022
07:26AM EST  BioSig Technologies Granted U.S. Patent #11,229,391 'Apparatus for processing biomedical signals for display'   Benzinga
Jan 7, 2022
10:20AM EST  BioSig to Present at the 27th Annual International AF Symposium   GlobeNewswire Inc
Jan 6, 2022
08:30AM EST  BioSig to Present at the 24th Annual Virtual Needham Growth Conference   GlobeNewswire Inc
Dec 21, 2021
09:00AM EST  BioSig Technologies, Inc. Selects Access Strategy Partners to   GlobeNewswire Inc
Dec 16, 2021
09:15AM EST  BioSig Expands Its Clinical Footprint In Florida   GlobeNewswire Inc
Dec 13, 2021
08:30AM EST  BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would host a conference call on Tuesday, December 21, 2021, at 2 PM ET.   GlobeNewswire Inc
Dec 6, 2021
10:00AM EST  BioSig to Participate in the Benzinga All Access Event on December   GlobeNewswire Inc
Dec 1, 2021
09:25AM EST  BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the appointment of Gray Fleming as Chief Commercial Officer.   GlobeNewswire Inc
Nov 17, 2021
09:45AM EST  BioSig to Participate in the The Benchmark Company 10th Annual   GlobeNewswire Inc
Nov 16, 2021
09:52AM EST  BioSig Initiates Artificial Intelligence Development Program with Technion Israel Institute Of Technology   Benzinga
09:52AM EST  BioSig Initiates Artificial Intelligence Development Program with   GlobeNewswire Inc
Nov 11, 2021
02:45PM EST  BioSig to Host Live Roundtable Webinar to Discuss Clinical Data   GlobeNewswire Inc
Nov 10, 2021
09:22AM EST  BioSig Adds To Its Clinical Footprint In Texas With Installation Of PURE EP System In Medical City Heart Hospital   Benzinga
09:20AM EST  BioSig Adds To Its Clinical Footprint In Texas   GlobeNewswire Inc
Nov 8, 2021
11:33AM EST  BioSig Installs Signal Processing Technology For Arrhythmia Care At Leading Hospital In Boston   Benzinga
11:30AM EST  BioSig Installs its Signal Processing Technology for Arrhythmia   GlobeNewswire Inc
Nov 4, 2021
11:02AM EDT  BioSig Technologies Reports Expansion Of Its Installation Base In Texas   Benzinga
Nov 1, 2021
12:31PM EDT  UPDATE: BioSig Sees Completing 1.7K-1.8K Procedures By End Of 2021   Benzinga
12:30PM EDT  BioSig Technologies Reports Exceeded Its Procedural Target Of 1,500 Patient Cases In 2021   Benzinga
12:30PM EDT  BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it exceeded its procedural target of 1500 patient cases in 2021.   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock   Benzinga
Oct 12, 2021
09:16AM EDT  BioSig Technologies Reports Its PURE EP System Will Be Featured In A Live Patient Case During Int'l. Symposium On Ventricular Arrhythmias   Benzinga
09:15AM EDT  BioSigs PURE EP System to be Featured in a Live   GlobeNewswire Inc
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
Oct 7, 2021
12:41PM EDT  BioSig Inks Manufacturing Deal with Plexus Corp   Benzinga
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
Oct 6, 2021
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Oct 5, 2021
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
Oct 4, 2021
08:40AM EDT  BigSig Technologies Highlights Publication Of Article 'Evaluation of a novel cardiac signal processing system for electrophysiology procedures: the PURE EP 2.0 study' In Journal Of Cardiovascular Electrophysiology   Benzinga
08:30AM EDT  Clinical Data Acquired by the PURE EP System   GlobeNewswire Inc
Sep 28, 2021
09:17AM EDT  BioSig Selects Plexus Corp. As Manufacturing Partner; Terms Not Disclosed   Benzinga
09:15AM EDT  BioSig Selects Plexus Corp. as its Manufacturing Partner   GlobeNewswire Inc
Sep 23, 2021
09:47AM EDT  BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients   Benzinga
Sep 21, 2021
10:30AM EDT  BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the appointment of James J. Barry, Ph.D. as an Independent Director to its Board of Directors.   GlobeNewswire Inc
Sep 17, 2021
07:41AM EDT  BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation   Benzinga
Sep 13, 2021
08:00AM EDT  BioSig Increases Installation Footprint Adding St.   GlobeNewswire Inc
Aug 31, 2021
10:00AM EDT  BioSig Confirmed as a Participant of The Mark E. Josephson   GlobeNewswire Inc
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 19, 2021
11:00AM EDT  BioSig's Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium   Benzinga
11:00AM EDT  BioSigs Signal Processing System for Arrhythmia   GlobeNewswire Inc
Jul 26, 2021
04:47PM EDT  EXCLUSIVE: BioSig CEO, Ken Londoner, Comments On Data Release From Earlier Today 'The quality of our data will aid the company in its goal of commercializing its platform technology.'   Benzinga
04:37PM EDT  EXCLUSIVE: BioSig CEO, Ken Londoner Says 'The quality of our data will aid the company in its goal of commercializing its platform technology.'   Benzinga
Jul 20, 2021
02:00PM EDT  BioSig To Host Presentations from Physician Users of its Signal   GlobeNewswire Inc
Jul 13, 2021
02:31PM EDT  BigSig Technologies Reports Signed New Deal With Medical City North Hills In Texas For Clinical Evaluation Of Co.'s PURE EP Technology For Arrhythmia Care   Benzinga
02:30PM EDT  BioSig Latest Installation Broadens Clinical Footprint for its   GlobeNewswire Inc
Jul 12, 2021
10:33AM EDT  BioSig to Host Conference Call to Unblind Clinical Data Collected   GlobeNewswire Inc
Jul 7, 2021
04:10PM EDT  BioSig Announces Closing of Public Offering of Common Stock   GlobeNewswire Inc
09:37AM EDT  BioSig Technologies Reports Co. Installed Its Technology In A Leading New York City Hospital, No Terms Disclosed   Benzinga
09:36AM EDT  BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company installed its technology in a leading New York City hospital.   GlobeNewswire Inc
Jul 6, 2021
09:45AM EDT  BioSig Technologies Shares Spike Higher; Co Says Received New Purchase Oder From Mayo Foundation For Medical Education And Research; Says Institution Commenced Evaluation Of Pure EP System In April 2021   Benzinga
09:44AM EDT  Mayo Clinic Purchases BioSig's PURE EP for use at its Phoenix Location   Benzinga
Jul 2, 2021
09:37AM EDT  BioSig Technologies Raises $10M Via Equity Issued At $4/Share   Benzinga
08:16AM EDT  BioSig Announces Pricing of Public Offering Of 2.5M Shares Of Common Stock At $4/Share   Benzinga
08:15AM EDT  BioSig Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
07:38AM EDT  The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures   Benzinga
06:35AM EDT  A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Report   Benzinga
Jul 1, 2021
04:06PM EDT  BioSig Announces Proposed Public Offering Of Common Stock; Size Not Disclosed   Benzinga
04:05PM EDT  BioSig Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Jun 30, 2021
02:58PM EDT  BioSig Completes 1,000 Patient Cases and Expects 1,500 more at the end of 2021   Benzinga
10:04AM EDT  BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology   Benzinga
09:36AM EDT  BioSig Says Completes 1000 Patient Cases With Its Signal Processing System For Electrophysiology   Benzinga
09:35AM EDT  BioSig Completes 1000 Patient Cases with its Signal Processing   GlobeNewswire Inc
Jun 28, 2021
09:47AM EDT  BioSig Says Co's Signal Processing Technology For Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat   Benzinga
09:45AM EDT  BioSigs Signal Processing Technology for   GlobeNewswire Inc
Jun 22, 2021
10:07AM EDT  BioSig Technologies Says Signal Processing System For Electrophysiology Featured In 2 Clinical, Scientific Presentations At Heart Rhythm 2021 Convention   Benzinga
10:06AM EDT  BioSigs Signal Processing System for   GlobeNewswire Inc
Jun 15, 2021
08:30AM EDT  BioSig Technologies, Inc. to Present New Clinical Data at Heart   GlobeNewswire Inc
Jun 7, 2021
08:30AM EDT  BioSig Technologies, Inc. to Present at the LD Micro Invitational   GlobeNewswire Inc
May 28, 2021
10:30AM EDT  BioSig Technologies, Inc. to Present at the Jefferies Virtual   GlobeNewswire Inc
May 26, 2021
09:52AM EDT  The Power and Precision of BioSig's PURE EP System in the Electrophysiology (EP) Market   Benzinga
May 21, 2021
09:15AM EDT  BioSig Technologies, Inc. to Present at the Oppenheimer MedTech,   GlobeNewswire Inc
May 4, 2021
06:30PM EDT  BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System   Benzinga
09:15AM EDT  BioSig Sees Increased Case Volume from Expanding Base of Medical   GlobeNewswire Inc
May 3, 2021
12:00PM EDT  BioSig Technologies, Inc. Invited to Present at Wall Street Conference   GlobeNewswire Inc
Apr 27, 2021
12:34PM EDT  Exclusive: BioSig's Cardiac Signal Processing System Now Used At Mayo Clinic's Phoenix Campus   Benzinga
09:30AM EDT  BioSigs PURE EP(tm) System Evaluated with   GlobeNewswire Inc
09:18AM EDT  BioSig's Cardiac Signal Processing System Now Used At Mayo Clinic's Phoenix Campus   Benzinga
09:15AM EDT  BioSig Announces Mayo Clinic's Phoenix Campus Has Started Using Co.'s PURE EP System To Treat Cardiac Arrhythmias   Benzinga
Apr 15, 2021
11:45AM EDT  BioSig Expands Commercial Team in Two Strategic Regions   GlobeNewswire Inc
Apr 14, 2021
09:30AM EDT  BioSig Technologies Highlights Release Of PURE EP Software Version 4   Benzinga
09:29AM EDT  The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular heartbeats   GlobeNewswire Inc
Apr 13, 2021
09:35AM EDT  BioSig Says Completes Enrollment In PURE EP 2.0 Clinical Study   Benzinga
09:32AM EDT  BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study   GlobeNewswire Inc
Apr 9, 2021
09:34AM EDT  BioSig Technologies Says Invited To Join Alliance For Artificial Intelligence In Healthcare   Benzinga
09:32AM EDT  BioSig Invited to Join Alliance for Artificial Intelligence in   GlobeNewswire Inc
Apr 8, 2021
09:33AM EDT  BioSig Technologies Reports EP Lab Digest Features Physician Experience With Co.'s Cardia Signal Acquisition Technology   Benzinga
09:32AM EDT  EP Lab Digest Features Physician Experience with   GlobeNewswire Inc
Apr 6, 2021
09:47AM EDT  BioSig Says Lands Commercial Sales To Leading Hospital System   Benzinga
09:45AM EDT  BioSig lands Commercial Sales to Leading Hospital System   GlobeNewswire Inc
Apr 5, 2021
10:00AM EDT  BioSig Technologies, Inc. to Present at the 20th Annual Needham   GlobeNewswire Inc
Mar 30, 2021
08:37AM EDT  BioSig Awarded US Patent Claims For Noise-Filtering Methods For Its Signal Processing Technology   Benzinga
08:30AM EDT  BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods   GlobeNewswire Inc
Mar 29, 2021
09:18AM EDT  BioSig Issues Shareholder Letter   Benzinga
09:15AM EDT  BioSig Issues Shareholder Letter with Corporate Update on Recent   GlobeNewswire Inc
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 25, 2021
12:33PM EDT  From BZ Biotech Conference: BioSig Technologies CEO Kenneth Londoner Says Co. Expects To Triple Customer Base In 2021   Benzinga
12:29PM EDT  From BZ Biotech Conference: BioSig Technologies CEO Kenneth Londoner Says Co. Is Building An Artificial Intelligence Business   Benzinga
12:27PM EDT  From BZ Biotech Conference: BioSig Technologies CEO Kenneth Londoner Says Its Pure EP System Allows Doctors To Detect Information More Efficiently   Benzinga
12:25PM EDT  From BZ Biotech Conference: BioSig Technologies CEO Kenneth Londoner Says Pure EP System Allows Doctor To Detect Information More Efficiently   Benzinga
Mar 19, 2021
12:15PM EDT  BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech   GlobeNewswire Inc
Mar 10, 2021
05:30PM EST  BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st   GlobeNewswire Inc
Mar 9, 2021
04:45PM EST  BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual   GlobeNewswire Inc
Mar 5, 2021
09:44AM EST  The Future of Medicine is Here: Bioelectronic Medicine   Benzinga
Mar 4, 2021
09:19AM EST  BioSig Awarded U.S. Patent Claims for its   Benzinga
Feb 16, 2021
08:45AM EST  BioSig Technologies, Inc. (NASDAQ: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it appointed Ms. Brenda Castrodad to lead its Human Resources department.   GlobeNewswire Inc
Feb 11, 2021
08:31AM EST  Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027   PR Newswire
Feb 10, 2021
10:02AM EST  BioSig Reports 3 New Evaluation Deals For PURE EP System, Its Electrophysiology Signal Acquisition, Analysis Technology, No Terms Disclosed   Benzinga
10:00AM EST  Major Medical Centers Enter into Installation Agreements for   GlobeNewswire Inc
Feb 8, 2021
08:35AM EST  Small and Microcap Company Investor Presentations Now Available for On-Demand   PR Newswire
Feb 2, 2021
08:08AM EST  BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP System   Benzinga
08:01AM EST  BioSig and Mayo Clinic Collaborate on New R&D Program to Develop   GlobeNewswire Inc
Jan 28, 2021
08:35AM EST  Live Investor Conference & Webinar: Small and Microcap Company Showcase on   PR Newswire
Jan 27, 2021
04:30PM EST  BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor   GlobeNewswire Inc
Jan 15, 2021
09:32AM EST  BioSig to Present at the 26th Annual International AF Symposium   GlobeNewswire Inc
Jan 14, 2021
09:32AM EST  BioSig PURE EP System Featured in the Editorial of EP Lab Digest   GlobeNewswire Inc
Jan 13, 2021
02:01PM EST  Vuzix Reiterates Earlier News Co's M400 Smart Glasses To Support BioSig's PURE EP System Rollout To Hospitals Nationwide   Benzinga
09:33AM EST  BioSig Reports Vuzix M400 Smart Glasses Deployed To Offer Remote Servicing Capabilities In Compliance With COVID-19 Travel Restrictions   Benzinga
09:32AM EST  BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing   GlobeNewswire Inc
Jan 12, 2021
09:33AM EST  BioSig Conducts First Patient Cases With PURE System At Memorial Hospital Of South Bend, Indiana   Benzinga
09:32AM EST  BioSig Conducts First Patient Cases with PURE EP(tm) System at   GlobeNewswire Inc
Jan 6, 2021
10:00AM EST  BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter   GlobeNewswire Inc
Jan 4, 2021
09:02AM EST  BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System   Benzinga
Dec 18, 2020
08:37AM EST  BioSig, NeuroClear Technologies Division Sign New Research Deal With The University Of Minnesota   RTTNews
08:35AM EST  BioSig's Division NeuroClear Technologies Signs Research Agreement With University Of Minnesota   Benzinga
08:30AM EST  BioSigs Division NeuroClear Technologies Signs a   GlobeNewswire Inc
Dec 16, 2020
09:45AM EST  BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System   Benzinga
Dec 11, 2020
07:52AM EST  BioSig Announces First Sale Of Cardiac Signal Processing Systems   Benzinga
07:32AM EST  BioSig Highlights First Commercial Sale Of 3 PURE EP Systems   Benzinga
07:30AM EST  BioSig Achieves First Commercial Sale of Three PURE EP Systems   GlobeNewswire Inc
Dec 10, 2020
03:00PM EST  BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD   GlobeNewswire Inc
Dec 9, 2020
09:05AM EST  From BZ Small Cap Event: BioSig Technologies CEO Highlights Co. Has No Debt, Has Enough Cash To Drive Business For Years   Benzinga
09:04AM EST  From BZ Small Cap Event: BioSig Technologies CEO Thinks 2021 Will Be A Strong Year For Commercialization For The Co.   Benzinga
09:04AM EST  From BZ Small Cap Event: BioSig Technologies CEO Highlights The Company Sells Service Agreements And Software Modules   Benzinga
09:04AM EST  From BZ Small Cap Event: BioSig Technologies CEO Kenneth L. Londoner Highlights Global EP Market Expected To Be $12.2B By 2026   Benzinga
Dec 8, 2020
02:47PM EST  From BZ Small Cap Event: BioSig Technologies CEO Highlights Co. Has No Debt, Has Enough Cash To Drive Business For Years   Benzinga
02:43PM EST  From BZ Small Cap Event: BioSig Technologies CEO Highlights No Debt, Has Enough Cash To Drive Business For Years   Benzinga
02:42PM EST  From BZ Small Cap Event: BioSig Technologies CEO Thinks 2021 Will Be A Strong Year For Commercialization For The Co.   Benzinga
02:41PM EST  From BZ Small Cap Event: BioSig Technologies CEO Highlights The Company Sells Service Agreements And Software Modules   Benzinga
02:37PM EST  From BZ Small Cap Event: BioSig Technologies CEO Kenneth L. Londoner Highlights Global EP Market Expected To Be $12.2B By 2026   Benzinga
Dec 7, 2020
05:22PM EST  Schedule Of NYSE-, Nasdaq-Listed Publicly-Traded Companies Presenting At Benzinga's Small Cap Conference Dec. 8-9   Benzinga
Dec 3, 2020
11:00AM EST  BioSig to Highlight PURE EP System at the   GlobeNewswire Inc
Dec 2, 2020
11:41AM EST  Insider Buys BioSig Technologies Stock   Benzinga
Nov 30, 2020
11:00AM EST  BioSigs PURE EP System to Support Live Patient   GlobeNewswire Inc
Nov 19, 2020
11:32AM EST  Insider Buys BioSig Technologies Shares   Benzinga
Nov 12, 2020
02:11PM EST  BioSig to Host Business Update Conference Call on November 18, 2020   GlobeNewswire Inc
Oct 29, 2020
02:07PM EDT  BioSig Announces Completion Of PURE EP System Installation At New Medical Center   Benzinga
Oct 28, 2020
10:00AM EDT  BioSig Technologies Sends Shareholder Update Letter For Month Of Oct.   Benzinga
10:00AM EDT  BioSig Issues October 2020 Shareholder Update Letter   GlobeNewswire Inc
Oct 26, 2020
02:37PM EDT  Mid-Afternoon Market Update: Crude Oil Down Over 3%; SAP Shares Slide On Lowered Outlook   Benzinga
12:34PM EDT  Mid-Day Market Update: Dow Tumbles 650 Points; Lianluo Smart Shares Climb   Benzinga
10:18AM EDT  Mid-Morning Market Update: Markets Open Lower; Hasbro Reports Upbeat Profit   Benzinga
08:29AM EDT  Stocks Trading Near 52-Week Lows Before Open On Monday, Oct. 26, 2020: HYLN, BSGM, BXRX   Benzinga
07:33AM EDT  UPDATE: ViralClear Says 'the unblinded SMC detected an imbalance in survival rates in these NIAID Grade 3 patients between the placebo and merimepodib making it unlikely that the trial would meet its primary safety endpoints'   Benzinga
07:32AM EDT  BioSig Technologies Announces Its ViralClear Pharmaceuticals Subsidiary Has Halted Its Phase 2 Hospitalized COVID-19 Trial   Benzinga
07:30AM EDT  ViralClear halts its Phase 2 Hospitalized COVID-19 Trial   GlobeNewswire Inc
Sep 30, 2020
10:06AM EDT  Sorrento To Explore Its Agents In Combination With   RTTNews
09:27AM EDT  SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO   GlobeNewswire Inc
09:25AM EDT  ViralClear, Sorrento Explore Combination Antibody Plus Antiviral Therapy Against COVID-19   RTTNews
09:01AM EDT  Sorrento Therapeutics, ViralClear Enter Into Agreement To Explore Combination Antibody Plus Antiviral Therapy Against Coronavirus   Benzinga
Sep 22, 2020
02:31PM EDT  Mid-Afternoon Market Update: Dow Rises 100 Points; AIM ImmunoTech Shares Climb   Benzinga
12:11PM EDT  Mid-Day Market Update: Nasdaq Gains 60 Points; Vaccinex Shares Slide   Benzinga
10:56AM EDT  BioSig Technologies Reports Its ViralClear Pharma Subsidiary Expanded Ongoing Phase 2 Trial Size For Oral Anti-Viral For Treatment Of COVID-19   Benzinga
10:55AM EDT  ViralClear Expands Ongoing Phase 2 Trial Size for its Oral   GlobeNewswire Inc
Sep 21, 2020
11:01AM EDT  Reminder: ViralClear to Host Conference Call and Webcast on   GlobeNewswire Inc
Sep 15, 2020
10:01AM EDT  BioSig Releases PURE EP Study Abstract With Data Presented At European Society Of Cardiology's 'ESC Congress 2020'   Benzinga
10:00AM EDT  BioSig Releases PURE EP Study Abstract with Data Presented at   GlobeNewswire Inc
Sep 14, 2020
03:01PM EDT  BioSig Technologies Reports Abstract Accepted For Computing In Cardiology 2020   Benzinga
03:00PM EDT  BioSig Announces Abstract Acceptance to Computing in Cardiology 2020   GlobeNewswire Inc
10:30AM EDT  BioSig To Host Conference Call, Webcast On Sept. 15 To Discuss Unblinding Of PURE EP Human Data   Benzinga
10:30AM EDT  Reminder: BioSig to Host Conference Call and Webcast on September   GlobeNewswire Inc
Sep 9, 2020
12:16PM EDT  ViralClear to Host Conference Call on September 22, 2020, to   GlobeNewswire Inc
Sep 2, 2020
10:16AM EDT  -- Peer-reviewed, blinded, randomized data recently presented at ESC Congress 2020 -- Commercial market update discussion   GlobeNewswire Inc
Aug 25, 2020
08:30AM EDT  BioSig Technologies to Present at The LD 500 Virtual Conference   GlobeNewswire Inc
Aug 5, 2020
02:10PM EDT  ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory Board   GlobeNewswire Inc
Aug 4, 2020
09:25AM EDT  BioSig Installs PURE EP(tm) System at Massachusetts General Hospital   GlobeNewswire Inc
Aug 3, 2020
02:00PM EDT  BioSig Awarded CAGE Code by the Systems for Award Management (SAM)   GlobeNewswire Inc
Jul 30, 2020
01:04PM EDT  BioSig Technologies To Present At The Proactive Investors One2One Virtual Event On August 4   Benzinga
01:00PM EDT  BioSig Technologies to Present at the Proactive Investors One2One   GlobeNewswire Inc
Jul 23, 2020
08:30AM EDT  BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig or the Company), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced today that the Company would be presenting at LD Micros Zooming with LD on Monday, July 27, 2020.   GlobeNewswire Inc
Jul 20, 2020
01:50PM EDT  ViralClear Announces Formation of Its Scientific Advisory Board   GlobeNewswire Inc
Jul 17, 2020
02:45PM EDT  BioSig Shares See Volume Following Co. Press Release Highlighting Co. Will Participate In B Riley FBR Virtual Infectious Disease Summit On Jul 21.   Benzinga
02:43PM EDT  BioSig Technologies to Participate in the B Riley FBR Virtual   GlobeNewswire Inc
Jul 16, 2020
05:32PM EDT  BioSig Technologies, Inc. Adopts Stockholder Rights Agreement   Benzinga
Jul 13, 2020
01:44PM EDT  BioSig Technologies Announces Phase 2 Human Trail Of ViralClear's Anti-Viral For Coronavirus Underway At 4 Key Trial Sites   Benzinga
01:43PM EDT  Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC